OpenAlex
PricingAboutJobs
Log inGet started
Work

FDA Approval: Siltuximab for the Treatment of Patients with Multicentric Castleman Disease

HTML

Year: 2015
Type: article
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-14-1678
Authors: Albert Deisseroth, Chia-Wen Ko, Lei Nie, Jeanne F. Zirkelbach, Liang Zhao, Julie Bullock, Nitin Mehrotra, Pedro Del Valle, Haleh Saber, Christopher Sheth, Brenda Gehrke, Robert Justice, Ann Farrell, Richard Pazdur
Institutions: United States Food and Drug Administration, Center for Drug Evaluation and Research
Language: English

Topic: Viral-associated cancers and disorders
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: siltuximab, multicentric Castleman disease, FDA approval, interleukin-6, monoclonal antibodies, tumor response, symptom response, adverse effects, hyperuricemia, pruritus, HIV-negative patients
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2169461745
FWCI: 5.629
Cites: 14
Cited by: 110
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security